Besides, ECs in HCC exhibit increased activity in the fructose metabolism pathway, notably through the upregulation of fructose transporter SLC2A5 and the fructose-metabolizing enzyme ketohexokinase (KHK). The gene discussed is SLC2A5; the disease is hepatocellular carcinoma.